Evolus (EOLS) Change in Accured Expenses (2017 - 2026)

Evolus (EOLS) posted Change in Accured Expenses of -$3.7 million for Q1 2026, down 194.69% on a QoQ basis from $4.0 million in Q4 2025, and up 73.58% year-over-year from -$2.2 million in Q1 2025.

Evolus (EOLS) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Evolus' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$3.7 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 73.58% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 141.9% YoY) and the FY2025 annual result came in at -$6.4 million, down 191.2% from the prior year.
  • Change in Accured Expenses was -$3.7 million for Q1 2026 at Evolus, down from $4.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $7.9 million in Q2 2024 and bottomed at -$14.2 million in Q1 2025.
  • A 5-year average of $40588.2 and a median of $2.1 million in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 355.53% — and 2024, when it surged 278.36%.
  • Evolus' Change in Accured Expenses stood at -$5.1 million in 2022, then surged by 239.52% to $7.1 million in 2023, then dropped by 17.73% to $5.8 million in 2024, then slumped by 32.31% to $4.0 million in 2025, then sank by 194.69% to -$3.7 million in 2026.
  • Business Quant data shows EOLS's Change in Accured Expenses at -$3.7 million in Q1 2026, $4.0 million in Q4 2025, and $2.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.24 Bn 87.37 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn -
5 United Therapeutics 23.28 Bn 21.13 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 20.54 Bn 20.54 Bn - -
7 Viatris 20.31 Bn 18.50 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.55 Bn 12.12 Bn 785.00 Mn -
10 Evolus 407.09 Mn 357.30 Mn 48.90 Mn -3.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.74 Mn
Mar 31, 2026 -3.74 Mn
Dec 31, 2025 3.95 Mn
Dec 31, 2025 3.95 Mn
Sep 30, 2025 2.52 Mn
Sep 30, 2025 2.52 Mn
Jun 30, 2025 1.34 Mn
Jun 30, 2025 1.34 Mn
Mar 31, 2025 -14.17 Mn
Mar 31, 2025 -14.17 Mn
Dec 31, 2024 5.84 Mn
Dec 31, 2024 5.84 Mn
Sep 30, 2024 2.16 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 7.85 Mn
Jun 30, 2024 7.85 Mn
Mar 31, 2024 -8.87 Mn
Mar 31, 2024 -8.87 Mn
Dec 31, 2023 7.10 Mn
Dec 31, 2023 7.10 Mn